» Articles » PMID: 32391354

SOD1 Promotes Cell Proliferation and Metastasis in Non-small Cell Lung Cancer Via an MiR-409-3p/SOD1/SETDB1 Epigenetic Regulatory Feedforward Loop

Overview
Specialty Cell Biology
Date 2020 May 12
PMID 32391354
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Superoxide dismutase 1(SOD1) is a major antioxidant with oncogenic effects in many human cancers. Although SOD1 is overexpressed in various cancers, the clinical significance and functions of SOD1 in non-small cell lung cancer (NSCLC), particularly the epigenetic regulation of SOD1 in NSCLC carcinogenesis and progression have been less well investigated. In this study, we found that SOD1 expression was upregulated in NSCLC cell lines and tissues. Further, elevated SOD1 expression could promote NSCLC cell proliferation, invasion and migration. While inhibition of SOD1 expression induced NSCLC G1-phase cell cycle arrest and promoted apoptosis. In addition, miR-409-3p could repress SOD1 expression and significantly counteract its oncogenic activities. Bioinformatics analysis indicated that SET domain bifurcated histone lysine methyltransferase1 (SETDB1) was involved in the epigenetic regulation of miR-409-3p and SOD1 expression and functions in NSCLC cells. Identification of this miR-409-3p/SOD1/SETDB1 epigenetic regulatory feedforward loop may provide new insights into further understanding of NSCLC tumorigenesis and progression. Additionally, our results incicate that SOD1 may be a potential new therapeutic target for NSCLC treatment.

Citing Articles

RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3/CBR3-AS1/miR-409-3p/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer.

Hu S, Zhan N, Li J, Wang L, Liu Y, Jin K J Transl Med. 2025; 23(1):191.

PMID: 39962467 PMC: 11831794. DOI: 10.1186/s12967-025-06205-y.


Druggable genome CRISPRi screen in 3D hydrogels reveals regulators of cortactin-driven actin remodeling in invading glioblastoma cells.

Hu M, Weldy A, Lovalvo I, Akins E, Jain S, Chang A bioRxiv. 2025; .

PMID: 39896608 PMC: 11785026. DOI: 10.1101/2025.01.20.633978.


SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1.

Fan X, Zhu Q, Du C, Chen J, Su Y J Cardiothorac Surg. 2025; 20(1):51.

PMID: 39780196 PMC: 11715545. DOI: 10.1186/s13019-024-03298-2.


The function of histone methyltransferase SETDB1 and its roles in liver cancer.

Zhang E, He P Front Cell Dev Biol. 2024; 12:1500263.

PMID: 39583200 PMC: 11582049. DOI: 10.3389/fcell.2024.1500263.


Bioinformatics analysis reveals is a prognostic factor in lung adenocarcinoma.

Gao L, Wang W, Ma H, Yin M, Yang X, Han R Transl Cancer Res. 2024; 13(10):5522-5534.

PMID: 39525006 PMC: 11543046. DOI: 10.21037/tcr-24-1400.


References
1.
Brasil A, de Carvalho M, Gerhardt E, Queiroz D, Pereira M, Outeiro T . Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc Natl Acad Sci U S A. 2019; 116(51):25991-26000. PMC: 6926019. DOI: 10.1073/pnas.1902483116. View

2.
Afonso V, Santos G, Collin P, Khatib A, Mitrovic D, Lomri N . Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic Biol Med. 2006; 41(5):709-21. DOI: 10.1016/j.freeradbiomed.2006.05.014. View

3.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

4.
Lin J, Zahurak M, Beer T, Ryan C, Wilding G, Mathew P . A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer. Urol Oncol. 2011; 31(5):581-8. PMC: 3227793. DOI: 10.1016/j.urolonc.2011.04.009. View

5.
Liu C, Hu F, Xia M, Han L, Zhang Q, Guo A . GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018; 34(21):3771-3772. DOI: 10.1093/bioinformatics/bty411. View